Clinical Trial Update: Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing buccal versus intranasal administration of midazolam spray for behavior management in pre-school dental patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Anxiety

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Nourhan M.Aly | Conditions: Dental Anxiety | Phase 2 | Status: COMPLETED